These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16983937)

  • 21. Evaluation of indicators of erythropoiesis stimulated by recombinant human erythropoietin in renal anemia.
    Schmidt G; Stamminger G; Daniel A; Gross J; Syllm-Rapoport I; Lun A; Zoellner K
    Biomed Biochim Acta; 1990; 49(2-3):S275-9. PubMed ID: 2386517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
    Korbet SM
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
    Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
    Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
    Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
    Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of erythropoietin before the initiation of dialysis and its impact on mortality.
    Fink J; Blahut S; Reddy M; Light P
    Am J Kidney Dis; 2001 Feb; 37(2):348-55. PubMed ID: 11157377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients.
    Furuya R; Odamaki M; Kumagai H; Hishida A
    Nephrol Dial Transplant; 2006 Feb; 21(2):494-8. PubMed ID: 16221697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mean transit time and functional image in asialoglycoprotein receptor scintigraphy: a novel modality for evaluating the regional dynamic function of hepatocytes.
    Ohno Y; Ishida H; Hayashi A; Kamagata S; Hirobe S; Ishii K
    J Nucl Med; 2002 Dec; 43(12):1611-5. PubMed ID: 12468509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietin.
    Conlon PJ; O'Neill S; O'Neill G; Kelly F; Donohoe J
    Clin Nephrol; 1994 Feb; 41(2):83-5. PubMed ID: 8004833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project.
    Brem AS; Lambert C; Hill C; Kitsen J; Shemin DG
    Am J Kidney Dis; 2000 Aug; 36(2):310-7. PubMed ID: 10922309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in anemic predialysis chronic kidney disease patients from an observational study.
    Papatheofanis F; Smith C; Mody S; McKenzie RS; Bookhart B; Piech CT
    Am J Ther; 2007; 14(4):322-7. PubMed ID: 17667204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Related to Erythropoietin Hyporesponsiveness in Peritoneal Dialysis Patients with Anemia.
    Makruasi N; Changsirikulchai S; Janma J; Rattanamongkolgul S
    J Med Assoc Thai; 2016 Nov; 99 Suppl 8():S48-S52. PubMed ID: 29901907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow changes following treatment of renal anemia with erythropoietin.
    Horina JH; Schmid CR; Roob JM; Winkler HM; Samitz MA; Hammer HF; Pogglitsch H; Krejs GJ
    Kidney Int; 1991 Nov; 40(5):917-22. PubMed ID: 1762296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B; Selgas R; Riñon C; Fernandez-Zamorano A; Borrego F; Ortuño F; Lopez-Revuelta K; Torre A; Sanchez Sicilia L
    Adv Perit Dial; 1990; 6():296-301. PubMed ID: 1982831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory mechanisms of erythropoietin levels in dialysis patients.
    Tagawa H; Umezu M; Saito T; Yamakado M; Nagano M; Urabe A; Takaku F
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):297-303. PubMed ID: 2355666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level.
    Andrassy M; Bierhaus A; Hong M; Sis J; Schiekofer S; Humper PM; Chen J; Haap M; Renn W; Schleicher E; Häring HU; Andrassy K; Nawroth PP
    Clin Nephrol; 2002 Sep; 58(3):179-89. PubMed ID: 12357990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.
    Guerrero-Riscos MÁ; Montes-Delgado R; Seda-Guzmán M; Praena-Fernández JM
    Nefrologia; 2012 May; 32(3):343-52. PubMed ID: 22535158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.